Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Overview
Select Medical Holdings Corporation (NYSE: SEM) is a prominent healthcare organization that provides a full continuum of care with a focus on critical illness recovery, rehabilitation, and occupational health services. With a proven track record of clinical quality and operational excellence, Select Medical has built a robust platform in the United States by offering specialized medical recovery solutions and health services. The organization is characterized by its diverse network of facilities and its commitment to delivering patient-first care.
Business Segments and Services
Select Medical operates through four key segments that define its comprehensive service offerings:
- Critical Illness Recovery Hospitals: These facilities cater to patients who have emerged from life-threatening conditions and require extended support to regain their health. They focus on advanced medical care and prolonged recovery services.
- Rehabilitation Hospitals: Designed for inpatient care, these hospitals offer specialized therapies and medical oversight to patients recovering from strokes, spinal cord injuries, brain injuries, orthopedic conditions, and other complex health events.
- Outpatient Rehabilitation Clinics: Through a large network of clinics, Select Medical provides accessible outpatient rehabilitation services encompassing physical therapy, occupational therapy, and specialized recovery programs.
- Occupational Health Centers (Concentra): Focused on workplace and direct-to-employer care, the Concentra segment provides preventive health screenings, injury care, and comprehensive occupational medicine services to support the health and productivity of the workforce.
Operational Excellence and Clinical Commitment
The company maintains its founding principles by emphasizing clinical quality and a patient-first philosophy. Every facility within the Select Medical network reflects the company's core values by striving for optimal patient outcomes and compassionate care. With a strong emphasis on operational efficiency, clinical partnerships, and continuous improvement, Select Medical ensures that every stage of the care journey—from the acute recovery phase to outpatient follow-up—is managed with precision and expertise.
Market Position and Competitive Landscape
In a competitive healthcare market, Select Medical distinguishes itself through its expansive network and integration of recovery and rehabilitation services. The combination of inpatient facilities and outpatient care centers allows Select Medical to offer a seamless continuum of services that meet the diverse needs of patients across the United States. The company's strategic focus on quality, safety, and outcomes underscores its position as a major player in the post-acute care sector. Furthermore, its dedicated approach to recruiting and training top healthcare professionals fortifies its reputation for exceptional care delivery.
Partnerships and Innovative Care Delivery
Select Medical has cultivated numerous joint ventures and partnerships with established healthcare institutions, enhancing its capacity to introduce innovative care models and specialized programs. For instance, collaborations with renowned medical centers underline the company's commitment to integrating advanced technologies and evidence-based practices into its clinical programs. These partnerships not only drive operational improvements but also pave the way for enhanced patient experiences and long-term health benefits.
Commitment to Quality and Community Impact
The foundation of Select Medical's operational strategy lies in its unwavering commitment to improving quality of life. The company’s patient-centric approach is evident in its comprehensive care programs, which are tailored to meet individual recovery needs and promote long-term wellness. Additionally, Select Medical’s extensive presence across multiple states and its continuous investment in clinical excellence underscore its dedication to serving communities and addressing the dynamic healthcare needs of a diverse patient population.
Conclusion
Overall, Select Medical Holdings Corporation exemplifies a robust healthcare model that integrates a variety of post-acute services across critical illness recovery, inpatient and outpatient rehabilitation, and occupational health. Its strategic organization, combined with an evergreen commitment to clinical quality, positions it as a vital component of the U.S. healthcare landscape. This detailed overview serves as a comprehensive resource that encapsulates the company's operational frameworks, industry expertise, and dedication to delivering quality care.
Select Medical has signed a definitive agreement to acquire Acuity Healthcare, enhancing its presence in long-term acute care. This acquisition includes four hospitals and one satellite location in New Jersey and West Virginia, expanding Select Medical's network to 104 facilities. The deal also establishes joint venture partnerships with AtlantiCare, Mon Health, Virtua Health, and physician partners to improve specialty care for critically ill patients. The acquisition is expected to close in Q3 2021, pending regulatory approval.
Select Medical and Northwest Healthcare announced a joint venture to acquire Curahealth Tucson, a long-term acute care hospital, subject to regulatory approval. Expected to close in early Q3 2021, this partnership aims to enhance specialty care for high-acuity patients in Tucson and expand Select Medical's presence in Arizona. The hospital will be relocated in September 2021 and rebranded as Select Specialty Hospital – Tucson Northwest. This venture is intended to provide seamless patient care transitions within the Northwest Healthcare system to improve overall patient outcomes.
Select Medical has launched its ReVital Cancer Rehabilitation Program in Chicago, partnering with 14 RUSH Physical Therapy centers. This innovative program aims to assist cancer patients in managing treatment-related side effects, enhancing physical function, and improving quality of life. Research indicates that approximately 60% of cancer patients face functional issues post-treatment, with many suffering from pain and fatigue. ReVital-certified therapists, trained in oncology rehabilitation, focus on holistic recovery for patients battling cancer.
Select Medical Holdings Corporation (NYSE: SEM) announced its first-quarter results for the period ending March 31, 2021. Revenue increased by 9.3% to $1.55 billion, with net income rising 94.8% to $137.2 million. The company declared a cash dividend of $0.125 per share, payable on June 1, 2021. Adjusted EBITDA grew by 37.9% to $258.3 million, and earnings per share improved to $0.82. Select Medical expects full-year revenue between $5.7 billion and $5.9 billion, and Adjusted EBITDA between $870 million and $900 million.
Select Medical Holdings Corporation (NYSE: SEM) has appointed Katherine R. Davisson to its Board of Directors, effective immediately. Her term will last until the 2022 Annual Meeting of Stockholders, where she will stand for re-election. Davisson boasts over 20 years of leadership experience in financial services, having worked at firms like Morgan Stanley and Goldman Sachs. She also has significant non-profit sector experience, including roles at the World Economic Forum. Her addition is expected to strengthen Select Medical's governance.
Select Medical Holdings Corporation (NYSE: SEM) will announce its first quarter financial results for the period ending March 31, 2021, on May 6, 2021, after market close. A conference call will be held on May 7, 2021, at 9:00 AM ET to discuss these results and the company's outlook. The call can be accessed via a domestic number (1-866-440-2669) or an international number (1-409-220-9844), with a conference ID of 8189262. Select Medical operates numerous healthcare facilities across the United States, including critical illness recovery hospitals and outpatient rehabilitation clinics.
Select Medical Holdings Corporation (NYSE: SEM) reported robust financial results for the fourth quarter and year ended December 31, 2020. Revenue rose 6.2% to $1.46 billion in Q4, with net income up 134.1% to $102.2 million. The year saw total revenue increase by 1.4% to $5.53 billion, while net income surged 71.4% to $344.6 million. Key segments, especially critical illness recovery hospitals, saw significant growth, aided by Provider Relief Fund payments of $36.2 million in Q4. Adjusted EBITDA for the year reached $800.6 million, representing a 12.6% increase compared to 2019.
Select Medical Holdings Corporation (NYSE: SEM) will disclose its fourth quarter and full year financial results for 2020 on February 25, 2021, after market closure. A conference call addressing the financial outcomes and the COVID-19 pandemic impact on operations is scheduled for February 26, 2021, at 9:00am ET. Investors can access the call via domestic line 1-866-440-2669 or internationally at 1-409-220-9844. A replay will be available until March 5, 2021.
Select Medical Holdings Corporation (NYSE: SEM) reported a 2.2% increase in net operating revenues to $1,423.9 million for Q3 2020, with net income soaring 137.2% to $104.5 million. The company achieved a 27% rise in operating income to $156.1 million. Adjusted EBITDA grew by 16.7% to $213.2 million. Despite these gains, the outpatient rehabilitation segment saw a revenue decline of 9.5% to $240 million. For the nine months ending September 30, 2020, revenues totaled $4,071.2 million, slightly declining from $4,079.3 million in the previous year.